|
LUND, Sweden, Jan. 30, 2019 /PRNewswire/ -- BioInvent International AB (OMXS: BINV) announces today that the U.S. Food and Drug Administration (FDA) has granted the Company orphan designation for its proprietary antibody BI-1206 for the treatment of mantle cell lymphoma (MCL).... Read more ›› |
By: PR Newswire Association LLC. - 30 Jan 2019
|
Related companies:
BioInvent International AB |
|
|
LUND, Sweden, Jan. 29, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), announces the publication of the results from a clinical phase I first-in-human study of the CD40 agonistic antibody ADC-1013 (JNJ-64457107). The top line data from this study was presented at... Read more ›› |
By: PR Newswire Association LLC. - 29 Jan 2019
|
Related companies:
Alligator Bioscience AB |
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 28 Jan 2019
|
Related companies:
Össur Nordic AB |
Össur Germany |
Össur Americas, Inc. |
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 28 Jan 2019
|
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 25 Jan 2019
|
Related companies:
AroCell AB |
|
|
TORONTO, January 25, 2019 /PRNewswire/ -- Read more ›› |
By: PR Newswire Association LLC. - 25 Jan 2019
|
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 25 Jan 2019
|
Related companies:
CELLAVISION AB |
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 25 Jan 2019
|
Related companies:
Enzymatica AB |
|
|
Elekta's cutting-edge hardware and software innovations are transforming cancer therapy and ushering radiation therapy into the age of personalized precision medicine Read more ›› |
By: PR Newswire Association LLC. - 25 Jan 2019
|
Related companies:
ELEKTA AB |
|
|
STOCKHOLM, Jan. 25, 2019 /PRNewswire/ --Cantargia AB (publ) today announce that the first patient in the phase IIa part of the CANFOUR clinical trial has received CAN04 (nidanilimab) treatment in accordance with the clinical protocol. The CANFOUR trial investigates the antibody CAN04 for... Read more ›› |
By: PR Newswire Association LLC. - 25 Jan 2019
|
Related companies:
Cantargia AB |
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 24 Jan 2019
|
Related companies:
C-RAD AB |
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 23 Jan 2019
|
Related companies:
Aino Health AB (publ) |
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 23 Jan 2019
|
Related companies:
Aino Health AB (publ) |
|
|
SHANGHAI, Jan. 23, 2019 /PRNewswire/ -- Led by the Shanghai Branch of PICC Health Insurance Co., Ltd. (PICC) and the Shanghai MediTrust Health Co., Ltd. as well as supported by Pfizer China, the "Bo'ai Xin'an - Patient Benefit Management Program for breast cancer patients" (hereinafter referred... Read more ›› |
By: PR Newswire Association LLC. - 23 Jan 2019
|
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 22 Jan 2019
|
Related companies:
Immunicum AB |
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 22 Jan 2019
|
Related companies:
Oasmia Pharmaceutical AB |
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 22 Jan 2019
|
|
|
SINGAPORE, Jan. 22, 2019 /PRNewswire/ -- Mundipharma will be introducing BETADINE(TM) Cold Defence, a new early treatment hailed as a "world-first" ([i]), in the Middle East and Africa to help families stay healthy and fight the common cold. Read more ›› |
By: PR Newswire Association LLC. - 22 Jan 2019
|
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 21 Jan 2019
|
|
|
Read more ›› |
By: Nasdaq / GlobenewsWire - 21 Jan 2019
|
Related companies:
Össur Nordic AB |
Össur Germany |
Össur Americas, Inc. |
|
|
|